Brokerages expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) to report $99.35 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Harmony Biosciences’ earnings. The highest sales estimate is $100.50 million and the lowest is $96.88 million. Harmony Biosciences posted sales of $73.82 million in the […]
PTC Therapeutics (NASDAQ:PTCT – Get Rating) and Harmony Biosciences (NASDAQ:HRMY – Get Rating) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Volatility and Risk PTC Therapeutics has a beta of […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) Director Jack Nielsen sold 4,195 shares of the business’s stock in a transaction dated Monday, April 18th. The shares were sold at an average price of $52.14, for a total value of $218,727.30. Following the transaction, the director now owns 3,982,398 shares in the company, valued at […]
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) Director Jack Nielsen sold 30,177 shares of the firm’s stock in a transaction that occurred on Wednesday, April 20th. The stock was sold at an average price of $52.14, for a total transaction of $1,573,428.78. Following the transaction, the director now directly owns 3,854,335 shares in the […]